Best Practices x2: Ketamine and GLP-1 Compounding | July 15, 2024
POWERED BY LP3 NETWORK
This webinar will be live on July 15th, 2024 at 6:00pm Eastern Daylight Time (EDT).
Overview
This CE activity focuses on equipping pharmacists with essential knowledge and skills in the dispensing of compounded ketamine and GLP-1 medications, preparations used for a variety of indications. The activity delves into the legal obligations, diversion concerns, dosing limits, dosage forms, documentation requirements, patient education, and constructive transfer protocols. Participants will also explore the basics of compounding a drug that is essentially a copy of a commercially available medication when that drug is in shortage.
Intended audience
- Pharmacists & Pharmacy Technicians
Learning Objectives
Pharmacists and Pharmacy Technicians
- Examine the documentation requirements for the compounding and dispensing process of ketamine, in accordance with regulatory standards and best practices, to foster comprehension of accountability and traceability principles.
- Review the legal obligations of pharmacists regarding controlled substances, including DEA and state regulations, and their implications for dispensing practices.
- Recognize the importance of implementing effective strategies for identifying signs of misuse or diversion through the utilization of the Prescription Drug Monitoring Programs (PDMPs) and thorough patient and prescriber verification processes.
- Recall FDA guidance on when a pharmacy can compound a drug that is "essentially a copy" of a FDA approved drug product, focusing on its implications for compounding of GLP-1 drugs listed on the FDA drug shortage list.
- Assess the considerations and challenges associated with compounding GLP-1 drugs listed on the FDA drug shortage list, including formulation adjustments, sourcing of ingredients, and maintaining quality assurance measures.
Hardware/software requirements
We will be using Zoom for this webinar - full system requirements can be found here. You can download the Zoom client here.
Web browser |
| ||
Internet connection |
| ||
Misc |
| ||
Hardware | Minimum | Recommended | |
Processor | Single-core 1Ghz or higher | Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent) | |
RAM | N/A | 4 GB |
COPYRIGHT
This webinar is Copyright © Alliance for Pharmacy Compounding 2024.
Tenille Davis, PharmD, RPh, BCSCP, FAPC |
Tenille Davis is a seasoned advocate and leader in the field of pharmacy compounding, currently serving as the Chief Advocacy Officer for the Alliance for Pharmacy Compounding.
Prior to her current position, Tenille spent 16 years at Civic Center Pharmacy, where she honed her skills and developed a deep understanding of pharmacy operations. Dr. Davis is also a Board Certified Sterile Compounding Pharmacist, a Fellow of the Alliance for Pharmacy Compounding, and a member of the Arizona State Board of Pharmacy.
Outside of her professional endeavors, Tenille finds fulfillment in her family life. She resides in Phoenix with her wife and twin daughters.
This activity is eligible for ACPE credit; see final CPE activity announcement for specific details.